Table III.
Variable | No. of patients (%) SS: n=197 |
---|---|
Total AEs | 44 (22.3) |
Study product-related AEs | 6 (3.1) |
Severe AEs | 2 (1.0) |
AEs leading to discontinuation | 3 (1.5) |
Study product-related AEs by type | |
Amaurosis | 1 (0.5) |
Dizziness | 3 (1.5) |
Headache | 1 (0.5) |
Hypotension | 1 (0.5) |
Pruritis | 1 (0.5) |
Mucosal and skin rash | 1 (0.5) |
Rash | 1 (0.5) |
SS, safety set; AE, adverse effect.